Blood pressure variability, a new risk factor for AMD
RetourThe results of the study on the links between blood pressure variability and AMD conducted by Blondy KAYEMBE MULUMBA, a PhD student in the LEHA team, have just been published in the journal Ophthalmology Science.
In a context of increasing life expectancy, and with it the prevalence of AMD, these results are crucial for providing clues for new preventive and therapeutic strategies
In 2023, Blondy KAYEMBE MULUMBA began his doctoral thesis entitled ‘Metabolic factors, smoking and the risk of age-related macular degeneration (AMD)’ under the supervision of Marie-Noelle Delyfer and Cécile Delcourt from the BPH-LEHA team.
Recently, the work of Blondy KAYEMBE MULUMBA was published in the journal Ophthalmology Science.
He obtained interesting results on the role of long-term blood pressure variability (BPV) in the development of age-related macular degeneration (AMD) in seniors as part of the ALIENOR cohort study.
In this article, we learn that Blondy and his team found that higher blood pressure fluctuations between medical visits were associated with an increased risk of advanced AMD, regardless of blood pressure levels.
These findings highlight a new risk factor for AMD.
What is encouraging for the prevention of this disease is that, once known, this risk factor can be avoided through preventive and therapeutic strategies.
This study is part of the MacuLife research project, led by Bénédicte Merle and funded by the Bordeaux University Foundation, AXA and Théa Laboratories, which aims to evaluate the impact of our lifestyles on the development of AMD in order to provide appropriate prevention measures.